Eli Lilly & Co. (LLY)

1071.64 -4.84 (-0.45%) USD  |  NYSE  |  Dec 23, 16:00
1071.65 +0.01 (+0.00%) Pre-Market: 05:32
More

Eli Lilly SG&A Expense (TTM): 10.39B for Sept. 30, 2025

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for LLY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
Amgen, Inc. 6.976B
Regeneron Pharmaceuticals, Inc. 2.717B
Adverum Biotechnologies, Inc. 59.84M
Viking Therapeutics, Inc. 52.36M
Moderna, Inc. 1.061B